An Arkansas bill passed today that aims to create a fairer pharmaceutical business market by restricting the abilities of pharmacy benefit managers.

The U.S. is seeing a "quad-demic" as cases of COVID-19, flu, RSV and norovirus spread at the same time. Experts said this is ...

Several rapid diagnostic tests are commercially available and many in-house assays have been developed but the performance characteristics of many of these tests have not been adequately evaluated.